Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) Stock Ticker

NASDAQ: CTNM · Healthcare · Biotechnology
$12.56+0.56%
USD · as of 2026-09-28 · market cap $472.5M
Open CTNM in TickrDownload for iPhone

CTNM right now

Down 26% in the last month.
Options expect by Oct 6±16.4%
Options expect by Oct 29±33.9%
Priced in for Oct 29 earnings±33.9%
IV rank (30-day)81% · rich
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full CTNM picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on CTNM
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.

CTNM stock facts

Ticker symbolCTNM
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Market cap$472.5M
CEOCarmine N. Stengone
Employees51
HeadquartersSan Diego, CA, US
IPO date2024-04-04
Websitewww.contineum-tx.com

What you can see for CTNM on Tickr

Live CTNM price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CTNM report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Contineum Therapeutics, Inc.?

The ticker symbol for Contineum Therapeutics, Inc. is CTNM, listed on the NASDAQ.

What is CTNM?

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary…

HomeExploreMarketLists
All pages